Last evening, Brent Saunders appeared on CNBC’s business television program Mad Money with Jim Cramer. In the feature interview, Brent discussed some of the many benefits of our proposed combination with Pfizer, including our complementary commitments to R&D, strong global footprints and world-class portfolios in key therapeutic categories.
Click here to watch the full interview. For more Company news, we invite you to follow us on Twitter @Allergan.